new england journal of medicine retatrutide What is Retatrutide UK Guide: Key Facts

The dosage is designed to start low and increase gradually to help your body adapt

Patients taking semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks, with 86.4% achieving at least 5% weight loss and nearly half losing 15% or more

Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A

Remember, it is always advisable to consult with a healthcare professional before starting any supplement regimen, as they can provide personalised guidance based on your specific needs and medical history

doi: 10.3390/ijms26020586

Outside clinical trials, cagrilintide exists primarily in the research chemical space